http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2404774-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fda45c540f11df3a7fe71d54a70562a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
filingDate 2006-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8d4aea4f8fdfb32f519ca527ebd7212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e95832084c757d793fa5a341a1dd5d00
publicationDate 2010-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2404774-C2
titleOfInvention Dispersed pills of bosentan
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to dispersed pills, containing 4-tret-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidine-2-yl)pyrimidine-4-yl]benzolsulfonamide (bosentan). Dispersed pill of bosentan also includes one or more fillers, one or more disintegrating agents, one or more glidants, one or more acidifying agents, one or more flavours, one of more sweeteners, one or more oiling agents. Dispersed pill of bosentan is fully destroyed in water at the temperature of 15-22°C for not more than 5 minutes. Dispersed pill of bosentan is produced by method of direct pressing. n EFFECT: production of medicinal agent for treatment of pulmonary arterial hypertension. n 4 cl, 1 dwg, 3 tbl, 3 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2559424-C1
priorityDate 2005-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453335048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID57918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421019667
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID89151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22245511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID57918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425172137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423352616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID51239
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID51239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51064083
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID89151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453559759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453635562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 51.